A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1479-5876
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma ; volume:17 ; number:1 ; day:26 ; month:11 ; year:2019 ; pages:1-10 ; date:12.2019
Journal of translational medicine ; 17, Heft 1 (26.11.2019), 1-10, 12.2019

Creator
Sarivalasis, Apostolos
Boudousquié, Caroline
Balint, Klara
Stevenson, Brian J.
Gannon, Philippe O.
Iancu, Emanuela Marina
Rossier, Laetitia
Martin Lluesma, Silvia
Mathevet, Patrice
Sempoux, Christine
Coukos, George
Dafni, Urania
Harari, Alexandre
Bassani-Sternberg, Michal
Kandalaft, Lana E.
Contributor
SpringerLink (Online service)

DOI
10.1186/s12967-019-02133-w
URN
urn:nbn:de:101:1-2020032200401699515891
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:49 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Sarivalasis, Apostolos
  • Boudousquié, Caroline
  • Balint, Klara
  • Stevenson, Brian J.
  • Gannon, Philippe O.
  • Iancu, Emanuela Marina
  • Rossier, Laetitia
  • Martin Lluesma, Silvia
  • Mathevet, Patrice
  • Sempoux, Christine
  • Coukos, George
  • Dafni, Urania
  • Harari, Alexandre
  • Bassani-Sternberg, Michal
  • Kandalaft, Lana E.
  • SpringerLink (Online service)

Other Objects (12)